Matt Patterson

Matthew R.
Patterson was the founder of Astellas Gene Therapies, Inc. (2012) and held the title of Chairman & Chief Executive Officer from 2018 to 2020.
Current jobs include Executive Chairman & Chief Executive Officer at Iris Medicine, Inc. (2021), Executive Chairman at Addition Therapeutics, Inc., Executive Chairman at Remix Therapeutics, Inc. (2021), Director at Gilda's Club New York City, Inc. (2010), Director at Modis Therapeutics, Inc. (2018), and Venture Partner at SR One Capital Management LP.
Former jobs include President & Chief Executive Officer at Amicus Therapeutics, Inc. (2004-2010), Chairman at Alliance for Regenerative Medicine (2018-2020), Independent Director at 5:01 Acquisition Corp.
(2020-2022), Independent Director at Vor Biopharma, Inc. (2020-2025), Independent Director at Homology Medicines, Inc., Vice President-Commercial Planning at BioMarin Pharmaceutical, Inc. (1998-2004), Senior Associate-Regulatory Affairs at Genzyme Corp.
(1993-1998), and Entrepreneur-in-Residence at OrbiMed Advisors Private Equity.
Education includes an undergraduate degree from Bowdoin College (1993).